STERIS’ (TSE:STE – Free Report) – Investment analysts at Atb Cap Markets lowered their Q4 2025 earnings per share estimates for shares of STERIS’ in a research report issued to clients and investors on Thursday, June 27th. Atb Cap Markets analyst W. Syed now expects that the company will post earnings of $0.03 per share for the quarter, down from their prior forecast of $0.04.
Separately, Stifel Canada downgraded shares of STERIS’ from a “buy” rating to a “hold” rating in a research report on Tuesday, March 12th.
STERIS’ Stock Performance
STERIS’ (TSE:STE – Get Free Report) last issued its quarterly earnings results on Wednesday, May 8th. The company reported C$0.55 earnings per share for the quarter, topping analysts’ consensus estimates of C$0.42 by C$0.13. The company had revenue of C$320.15 million during the quarter, compared to analysts’ expectations of C$289.75 million.
About STERIS’
STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe by providing innovative healthcare and life science product and service solutions around the globe.
Read More
- Five stocks we like better than STERIS’
- Best Stocks Under $5.00
- These Top 3 Banks Raise Dividends After Passing Fed Stress Test
- Consumer Discretionary Stocks Explained
- Hitch a Ride with Lyft Stock for Double-Digit Gains in 2nd Half
- How to Most Effectively Use the MarketBeat Earnings Screener
- Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market
Receive News & Ratings for STERIS’ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS’ and related companies with MarketBeat.com's FREE daily email newsletter.
